The nanoparticle production rate can vary but would generally be in the milligrams per hour range, depending greatly on the experimental conditions. For instance, a 100 nm liposome contains approximately 80,047 lipids, and depending on the material type, the total number of particles per milliliter can be calculated.
911917
NanoFabTx™ microfluidic chip
for 100-200 nm particles
Sinonimo/i:
Microfluidic kit, NanoFabTx™, Nanoformulation
Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Scegli un formato
1 EACH
417,00 €
Scegli un formato
Cambia visualizzazione
1 EACH
417,00 €
About This Item
Codice UNSPSC:
41116105
Codice UNSPSC:
41121800
NACRES:
NA.23
Prodotti consigliati
Descrizione
Microfludic hardware kit component for synthesizing nanoparticles
Kit components :
- Microfluidic chip x 1
Livello qualitativo
applicazioni
advanced drug delivery
Cerchi prodotti simili? Visita Guida al confronto tra prodotti
Descrizione generale
NanoFabTx™ microfluidic chip, for 100-200 nm particles is a component of our NanoFabTx™ microfluidic - nano, device kit for synthesis of 100-200 nm nanoparticles and liposomes (911593). The kit additionally includes a protocol, supporting manifold, tubing, and additional accessories for microfluidic-based synthesis.
Applicazioni
NanoFabTx™ microfluidic chips precisely control and manipulate fluids on the microscale. Their well-controlled geometries enable facile syntheses of monodisperse polymeric nanoparticles. NanoFabTx™ microfluidic chip, for 100-200 nm particles can be used as a replacement for the component in our NanoFabTx™ microfluidic - nano, device kit for synthesis of 100-200 nm nanoparticles and liposomes (911593).
Note legali
NANOFABTX is a trademark of Sigma-Aldrich Co. LLC
Prodotti correlati
N° Catalogo
Descrizione
Determinazione del prezzo
Scegli una delle versioni più recenti:
Certificati d'analisi (COA)
Lot/Batch Number
Ci dispiace, ma al momento non ci sono COA disponibili online per questo prodotto.
Se ti serve aiuto, non esitare a contattarci Servizio Clienti
Possiedi già questo prodotto?
I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.
Samar Damiati et al.
Genes, 9(2) (2018-02-22)
Microfluidic devices present unique advantages for the development of efficient drug carrier particles, cell-free protein synthesis systems, and rapid techniques for direct drug screening. Compared to bulk methods, by efficiently controlling the geometries of the fabricated chip and the flow
Xuanyu Li et al.
Advanced drug delivery reviews, 128, 101-114 (2017-12-27)
Microfluidic chips allow the rapid production of a library of nanoparticles (NPs) with distinct properties by changing the precursors and the flow rates, significantly decreasing the time for screening optimal formulation as carriers for drug delivery compared to conventional methods.
Andrew Gdowski et al.
Journal of nanobiotechnology, 16(1), 12-12 (2018-02-13)
The process of optimization and fabrication of nanoparticle synthesis for preclinical studies can be challenging and time consuming. Traditional small scale laboratory synthesis techniques suffer from batch to batch variability. Additionally, the parameters used in the original formulation must be
-
What is the approximate nanoparticle production rate per hour for microfluidic devices used in the production of both liposomes and polymersomes?
1 risposta-
Utile?
-
Filtri attivi
Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..
Contatta l'Assistenza Tecnica.
